Olumide Kayode

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Andrea E. Wahner Hendrickson, Michael E. Menefee, Lynn C. Hartmann et al. · Clinical Cancer Research · 2017 · 56 citations · Full text

Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer

Ravi Anchoori, Rosie Jiang, Shiwen Peng et al. · ACS Omega · 2018 · 35 citations · Full text

Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy

Itay Cohen, Olumide Kayode, Alexandra Hockla et al. · Biochemical Journal · 2016 · 34 citations · Full text

Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates

Alexandre P. Alloy, Olumide Kayode, Ruiying Wang et al. · Journal of Biological Chemistry · 2015 · 28 citations · Full text

Four Unique Residues, Protein Function, Trypsin Inhibitors +10

An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis

Olumide Kayode, Ruiying Wang, Devon F. Pendlebury et al. · Journal of Biological Chemistry · 2016 · 28 citations · Full text

Protein Chemistry, Protein Function, Biochemistry +9